|
Pre-intervention (July 2014)
|
|
dhfrN51I
|
38/48
|
79.2
|
50/58
|
86.2
|
0.42
|
|
dhfrC59R
|
39/48
|
81.2
|
54/58
|
93.1
|
0.07
|
|
dhfrS108 N
|
42/48
|
87.5
|
53/58
|
91.4
|
0.59
|
|
Triple dhfr (N51I, C59R, S108N)
|
37/48
|
77.1
|
49/58
|
84.8
|
0.45
|
|
dhps A437G
|
20/48
|
41.8
|
23/56
|
42.0
|
0.95
|
|
dhps K540E
|
6/48
|
12.5
|
2/58
|
3.4
|
0.11
|
|
Quintiple (triple dhfr+ dhpsA437G et K540E)
|
2/48
|
4.2
|
1/56
|
1.8
|
0.41
|
|
Pfmdr1-86Y
|
8/42
|
19.0
|
13/54
|
24.1
|
0.60
|
|
Pfcrt-76T
|
44/48
|
91.7
|
51/57
|
89.5
|
0.25
|
|
Post intervention (December 2014)
|
|
dhfrN51I
|
38/38
|
100
|
79/79
|
100
|
1
|
|
dhfrC59R
|
38/38
|
100
|
77/79
|
97.5
|
0.46
|
|
dhfrS108N
|
37/38
|
97.4
|
68/78
|
87.2
|
0.10
|
|
Triple dhfr (N51I, C59R, S108N)
|
37/38
|
97.4
|
66/78
|
87.2
|
0.10
|
|
dhps A437G
|
25/38
|
65.8
|
35/79
|
44.3
|
0.01
|
|
dhps K540E
|
1/38
|
2.6
|
5/79
|
6.3
|
0.47
|
|
Quintuple (triple dhfr+ dhpsA437G et K540E)
|
1/38
|
2.6
|
1/78
|
1.8
|
0.60
|
|
Pfmdr1-86Y
|
7/38
|
18.4
|
8/79
|
10.1
|
0.60
|
|
Pfcrt-76T
|
28/38
|
73.7
|
59/78
|
75.6
|
0.81
|
